Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Esperion Therapeutics, Inc. | 177,523 | reported | 28 May 2026 | tx 11+315,023 |
| ROCKET PHARMACEUTICALS, INC. | 45,000 | reported | 20 Jun 2017 | tx 5+142,000 |
| VIVUS INC | 25,000 | reported | 14 Aug 2013 | tx 2+45,000 |
| ACCREDO HEALTH INC | 6,074 | reported | 27 Jan 2004 | tx 2+9,111 |
| Catalent, Inc. | 0 | reported | 18 Dec 2024 | tx 25+63,795−56,060 |
| CROFF ENTERPRISES INC | 0 | reported | 10 Aug 2021 | tx 11+652,902−96,864 |
| Keenova Therapeutics plc | 0 | reported | 12 Mar 2021 | tx 31+129,172−129,172 |
| Durata Therapeutics, Inc. | 0 | reported | 17 Nov 2014 | tx 2+8,134−8,134 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 79,873 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 33,000 | 0.00 USD | |
| 29 May 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 44,000 | 0.00 USD | deriv |
| 18 Dec 2024 | OTHER | Catalent, Inc. | 32,734 | — | |
| 30 Oct 2024 | GRANT_AWARD | Catalent, Inc. | 4,663 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 23,000 | 0.00 USD | |
| 23 May 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 32,500 | 0.00 USD | deriv |
| 27 Oct 2023 | GRANT_AWARD | Catalent, Inc. | 6,993 | 0.00 USD | |
| 01 Jul 2023 | GRANT_AWARD | Catalent, Inc. | 555 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 5,150 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 21,000 | 0.00 USD | deriv |
| 11 May 2023 | PURCHASE | Esperion Therapeutics, Inc. | 23,091 | 1.57 USD | |
| 10 May 2023 | PURCHASE | Esperion Therapeutics, Inc. | 8,409 | 1.49 USD | |
| 27 Oct 2022 | GRANT_AWARD | Catalent, Inc. | 4,149 | 0.00 USD | |
| 02 Jun 2022 | PURCHASE | Esperion Therapeutics, Inc. | 5,000 | 5.64 USD | first after silence |
| 01 Jun 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 29 Nov 2021 | GIFT | Catalent, Inc. | 3,136 | 0.00 USD | |
| 29 Nov 2021 | OTHER | Catalent, Inc. | 3,136 | 134.12 USD | |
| 29 Nov 2021 | OTHER | Catalent, Inc. | 3,136 | 134.12 USD | |
| 29 Nov 2021 | GIFT | Catalent, Inc. | 3,136 | 0.00 USD | |
| 28 Oct 2021 | GRANT_AWARD | Catalent, Inc. | 1,402 | 0.00 USD | |
| 10 Aug 2021 | EXERCISE | CROFF ENTERPRISES INC | 96,864 | — | |
| 10 Aug 2021 | EXERCISE | CROFF ENTERPRISES INC | 96,864 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | CROFF ENTERPRISES INC | 99,174 | 0.00 USD | deriv |
| 12 Mar 2021 | SALE | Keenova Therapeutics plc | 31,398 | 0.40 USD |
3 purchases reported after at least 12 months of silence — most recent on 02 Jun 2022.